OBJECTIVE:
To assess the relative efficacy of three different omega-3 (n-3) polyunsaturated fatty acids (PUFAs) in suppressing the mRNA levels for important proteins involved in the etiology of osteoarthritis (OA). METHODS: A model cell culture system (bovine chondrocytes) was used. Inflammatory factors and enzymes involved in OA were induced by exposure of the chondrocyte cultures to interleukin-1alpha (IL-1alpha). The effect of pre-incubating cultures with various amounts of exogenous fatty acids on subsequent levels of mRNAs was assessed by reverse transcriptionpolymerase chain reactions (RT-PCR). RESULTS: Exposure of cultures to IL-1alpha induced expression of the cartilage proteinases A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS)-4 and ADAMTS-5, cyclooxygenase (COX)-2, the matrix metalloproteinase (MMP)-3 and the inflammatory cytokines IL-1alpha, interleukin-1beta (IL-1beta) and tumour necrosis factor-alpha (TNF-alpha). n-3 PUFAs were able to reduce the levels of mRNA for ADAMTS-4, ADAMTS-5, MMP-3, MMP-13, COX-2 (but not COX-1), IL-1alpha, IL-1beta and TNFalpha. Eicosapentaenoic acid (EPA) was the most effective, followed by docosahexaenoic (DHA) and then alpha-linolenic (ALA) acid. The n-6 PUFA, arachidonic acid (AA) had no effect. CONCLUSION: These results show that omega-3 (n-3) PUFAs cause a reduction in the mRNA levels for various proteins known to be important in the pathology of OA. They provide a molecular explanation, at least in part, for beneficial effects of dietary omega-3 PUFAs for the amelioration of symptoms of the disease. The relative efficacy of EPA suggests that this omega-3 PUFA may be especially useful for dietary supplementation in patients with OA. 
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They provide a molecular explanation, at least in part, for beneficial effects of dietary omega-3 PUFAs for the amelioration of symptoms of the disease. The relative efficacy of EPA suggests that this omega-3 PUFA may be especially useful for dietary supplementation in patients with OA. "Eicosapentaenoic acid (EPA) was the most effective, followed by docosahexaenoic (DHA) and then alpha-linolenic (ALA) acid. The n-6 PUFA, arachidonic acid (AA) had no effect."
Looks like fish oil is the thing for this.
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Jofirey -26 Feb 2009 00:12 GMT > Look's like you missed this the first time. What do you think? > [quoted text clipped -4 lines] > > Looks like fish oil is the thing for this.
Sorry, but based on family history, fish oil alone isn't going to do the trick.
My family (the side with all the autoimmune problems) is from Newfoundland. They practically lived on home canned salmon and other fish. I have the pictures to prove it didn't protect my great grandmother. It shows her hand in her wedding pictures and her hands again when she was about eighty. 
> > Jo
Of course Omega-3s won't protect you from arthritis! This is all about a play with the short term politically correct markers of inflammation. Go ahead with the fish oil and you loose all the remaining cartilage in your joints ... Omega-3s kill cartilage regeneration in addition to damaging the chondrocytes by lipid peroxidation. What you need for healthy cartilage is the Mead acid which you get only when consuming saturated fat and no PUFAs. The purpose of the study was to determine which of the active constituents of fish oil, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), is most effective in suppressing proinflammatory mediator generation and cytokine expression from LPSstimulated human asthmatic alveolar macrophages (AMφ). Methods The AMφ were obtained from twenty-one asthmatic adults using fiberoptic bronchoscopy. Cells were pretreated with DMEM, pure EPA, an EPA-rich media (45% EPA/10% DHA), pure DHA, a DHA-rich media (10% EPA/ 50% DHA) or Lipovenos(R) (n-6 PUFA), and then exposed to Dulbecco's Modified Eagle's Medium (DMEM) (-) or LPS (+). Supernatants were analyzed for leukotriene (LT)B4, prostaglandin (PG)D2, tumor necrosis factor (TNF)-α and interleukin (IL)-1β production. Detection of TNF-α and IL-1β mRNA expression levels was quantified by reverse transcriptase polymerase chain reaction.
Results 120 μM pure EPA and EPA-rich media significantly (p < 0.05) suppressed TNF-α and IL-1β mRNA expression and the production of LTB4, PGD2 and TNF-α and IL-1β in LPS-stimulated primary AMφ cells obtained from asthmatic patients to a much greater extent than 120 μM pure DHA and DHA-rich media respectively.
Conclusions
This study has shown for the first time that EPA is a more potent inhibitor than DHA of inflammatory responses in human asthmatic AMφ cells.
------------------------Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid.
